“Targeting Cellular Metabolism Through Modulation of BACH1 in Triple-Negative Breast Cancer” |
11/12/2018 - 12:00pm to 1:00pm |
“Targeting the Beta-Catenin Pathway to Overcome Immunotherapy Resistance of Beta-catenin Expressing Tumors” and “Diving into the Deep End: Minimal Residual Disease in Multiple Myeloma” |
10/15/2018 - 12:00pm to 1:00pm |
“TCR-T Cells: The Answer to Solid Tumor Immunology” and “Prognostic Implications of Driver Mutations in AML” |
08/13/2018 - 12:00pm to 1:00pm |
“The HNC Program: What it takes to Change the Standard of Care” |
11/26/2018 - 12:00pm to 1:00pm |
“The Impact of PTEN-Deficiency on Immunotherapy Response: Current Understanding and Future Directions” and “A Spotlight on the Hematologic Toxicities of Immune Checkpoint Inhibitors” |
10/29/2018 - 12:00pm to 1:00pm |
“The Influence of Gut Microbiome on Response to Cancer Immunotherapy: An Ongoing Quest” and “Circulating Tumor DNA: Barriers to a Liquid Biopsy Future” |
07/16/2018 - 12:00pm to 1:00pm |
“The Role of Bacterial Driven Inflammation in TET2 Mutated Clonal Hematopoiesis: Update and Future Directions” and “Clinical and Molecular Correlates of Immunotherapy Response and Resistance” |
10/22/2018 - 12:00pm to 1:00pm |
“Translating the Genome in Gastroesophageal Cancer” |
08/20/2018 - 12:00pm to 1:00pm |
“Treating Young Adults with Acute Leukemia: Therapeutic Progress and Challenges” |
04/22/2019 - 12:00pm to 1:00pm |
“Understanding Cancer-Immune Interactions through Data-Driven Mathematical Modeling” |
03/04/2019 - 12:00pm to 1:00pm |